Data protection Impressum

R&D

Nicolas Collin, Co-Founder and CEO of the Vaccine Formulation Institute (VFI), discusses the innovative approach and global impact of their work in developing high-quality, accessible adjuvants for vaccines and why Geneva was chosen as the ideal location for VFI's impactful work.

Why the Vaccine Formulation Institute chose Western Switzerland

23 January 2024

STALICLA has developed the first neurodevelopmental disorder-specific precision medicine platform with an initial application in autism spectrum disorder (ASD).

STALICLA secures USD 17.4 million to propel neuro precision medicine

22 January 2024

Eversys uses AI for predictive maintenance in coffee machines.

Eversys’ AI use for enhanced innovation in coffee machine production

16 January 2024

This funding and partnership with the ADDF place GliaPharm at the forefront of developing effective treatments for Alzheimer’s, offering new hope in the fight against this challenging neurodegenerative disease.

GliaPharm receives USD 4.2 million to propel Alzheimer’s treatment development

20 December 2023

This significant funding propels the Diatheris’ efforts to revolutionize type 1 diabetes management through innovative treatment methodologies (from left to right: Pr. Roberto Coppari and Dr Giorgio Rimadori).

Diatheris to spearhead a new era in Type 1 diabetes management

11 December 2023

Cytiva’s recent move underlines Western Switzerland’s Health Valley region's growing significance as a hub for healthcare technology.

Cytiva’s strategic expansion in Western Switzerland’s Health Valley

11 December 2023

Novochizol technology quantitatively transforms single linear chitosan molecules into cross-linked, uniformly sized nanospheres.

EPFL and Novochizol to collaborate on designing more efficient immunotherapies

2 November 2023

Marco Scicolone (to the left) and Alexander Fink (to the right) are looking forward to working together.

Regulatory compliance expert Metecon establishes its Swiss subsidiary in Bern

30 October 2023

Established in the canton of Valais since 1989, Debiopharm is building a full-scale research and innovation campus in Martigny.

Debiopharm invests CHF 30 million in Valais amidst workforce surge

26 October 2023

Western Switzerland's commitment to 3D printing and manufacturing is multi-faceted, bridging research, industry, and academia.

3D printing and manufacturing in Western Switzerland

25 October 2023

1 2 3 4 5 6 7 8 9 10 … 13